In a groundbreaking study unveiled by researchers at the Salk Institute, a novel pathway has been identified that could revolutionize treatments for muscle fatigue and metabolic disorders through the manipulation of estrogen-related receptors. These intricate proteins, which resemble classical estrogen receptors yet operate through distinct mechanisms, appear to hold the key to enhancing mitochondrial function within muscle cells — a discovery that may unlock new therapeutic potentials for a range of debilitating diseases.
Mitochondria, often described as the powerhouses of the cell, are essential organelles responsible for converting nutrients into adenosine triphosphate (ATP), the molecule that powers virtually all biological activities. Muscle tissues, known for their high energy demands, rely heavily on the proper functioning of mitochondria to sustain movement and endurance. However, mitochondrial dysfunction is a hallmark of numerous metabolic and neuromuscular disorders, including muscular dystrophy, multiple sclerosis, and age-related decline, posing a significant challenge for effective medical intervention.
The Salk team’s work delves deep into the molecular biology governing mitochondrial biogenesis — the process by which cells generate new mitochondria, especially in response to increased energy demands such as exercise. Central to this process are estrogen-related receptors (ERRs), members of the nuclear hormone receptor family, which regulate gene expression by binding directly to DNA. Unlike their classical counterparts, the functions of ERRs had remained largely elusive since their discovery in the late 1980s.
Through meticulous experimentation involving genetically engineered mouse models lacking various ERR isoforms — alpha, beta, and gamma — the researchers observed striking effects on mitochondrial quantity and functionality in muscle cells. Notably, deletion of ERRα alone produced mild changes due to compensation by the gamma isoform, which, although only constituting around 4% of the ERR population, exhibited a crucial compensatory role under resting conditions. Simultaneous elimination of both ERRα and ERRγ, however, precipitated severe mitochondrial abnormalities, underscoring their cooperative necessity in sustaining muscle metabolic capacity.
These findings suggest an evolutionary design wherein ERRα’s abundance primes muscles for rapid adaptation and growth in energy production in response to physiological stimuli. Indeed, when mice lacking ERRα were subjected to exercise regimes using mechanical running wheels, mitochondrial biogenesis — normally induced by physical activity — was completely blocked. This pivotal experiment illuminates the indispensable role of ERRα in enabling muscles to meet heightened energy demands, effectively acting as a gatekeeper of exercise-induced mitochondrial proliferation.
Historically, the protein PGC1α has been recognized as a master regulator of mitochondria across multiple tissues. Nonetheless, its therapeutic appeal is limited by its indirect interaction with DNA, necessitating partnership with nuclear receptors like ERRα to modulate gene transcription. The Salk study substantiates that ERRα directly binds to mitochondrial energy metabolism genes and synergizes with PGC1α to orchestrate the robust genomic response required for mitochondrial biogenesis during exercise.
The implications of these mechanistic insights are profound. By targeting ERRs, particularly ERRα, it may be possible to pharmacologically stimulate mitochondrial growth and enhance metabolic efficiency in individuals incapable of engaging in physical activity due to muscle weakness or chronic illness. Such interventions could ameliorate symptoms of metabolic dysfunction and muscle fatigue prevalent in a broad spectrum of disorders, including muscular dystrophies, aging-related sarcopenia, and systemic metabolic syndromes.
Moreover, ERRs’ expression in vital organs such as the heart and brain extends the therapeutic horizon beyond skeletal muscle. By potentiating mitochondrial energetics in these tissues, drugs designed to activate estrogen-related receptors might confer systemic benefits, potentially improving cardiovascular health and cognitive function through enhanced cellular bioenergetics.
This research represents a significant advance in understanding the transcriptional regulation of mitochondrial biogenesis and the intricate cellular pathways that sustain energy homeostasis. With estrogen-related receptors functioning as pivotal modulators, the door opens to innovative drug discovery programs focused on ERR agonists or modulators, heralding a new era in the management of metabolic and neuromuscular diseases.
Future investigations are warranted to unravel the precise regulatory networks between ERR isoforms and their interactions with co-regulators like PGC1α, as well as to explore the safety and efficacy of potential ERR-targeting compounds in clinical settings. Furthermore, elucidating the nuances of ERR regulation in various tissue contexts will be paramount to designing tailored therapeutics that maximize benefit and minimize adverse effects.
In synthesizing these findings, it becomes evident that the metabolic resilience of muscle and other high-energy organs hinges critically on the robust function of estrogen-related receptors. Their strategic activation could emulate the physiological benefits of exercise at the molecular level, offering hope for patients burdened by metabolic insufficiencies and expanding the arsenal against diseases rooted in mitochondrial dysfunction.
This seminal research, published in the prestigious Proceedings of the National Academy of Sciences on May 12, 2025, underscores the enduring importance of fundamental molecular biology in unveiling therapeutic targets with far-reaching clinical ramifications. As the Salk Institute continues to push the frontiers of knowledge, the scientific community eagerly anticipates the translation of these insights into tangible treatments that invigorate mitochondrial health and revitalize muscle function across diverse populations.
—
Subject of Research: Muscle mitochondrial energetics and estrogen-related receptor regulation
Article Title: Estrogen-related receptors regulate innate and adaptive muscle mitochondrial energetics through cooperative and distinct actions
News Publication Date: May 16, 2025
Web References: https://doi.org/10.1073/pnas.2426179122
Image Credits: Salk Institute
Keywords: Life sciences, Cell biology, Cellular physiology, Cell metabolism, Cellular energy, Animal cells, Muscle cells, Mitochondrial diseases, Metabolic disorders, Muscle diseases, Movement disorders, Mitochondria, Cell structure
Tags: age-related muscle decline solutionsclassical estrogen receptors comparisonenergy metabolism in muscle tissuesEstrogen-related receptorsmitochondrial biogenesis mechanismsmitochondrial function in muscle cellsmuscle fatigue therapiesneuromuscular disorder interventionsnuclear hormone receptor family rolesSalk Institute research findingstherapeutic potentials for muscular dystrophytreatment for metabolic disorders